Subtypes of pediatric delirium: A treatment algorithm

Psychosomatics

Volumn 48, Issue 3, 2007, Pages 253-257

  Karnik, Niranjan S ^a   Joshi, Shashank V ^a   Paterno, Caroline ^a   Shaw, Richard ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTINEOPLASTIC AGENT; ASPARAGINASE; CEFTAZIDIME; DANURUBICIN; DEXAMETHASONE; HALOPERIDOL; METHOTREXATE; PREDNISONE; RISPERIDONE; UNCLASSIFIED DRUG; VINCRISTINE; ZOLPIDEM;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADD ON THERAPY; ADOLESCENT; ALGORITHM; ARTICLE; CASE REPORT; DELIRIUM; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; FEVER; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS; HUMAN; HYPERACTIVITY; MYALGIA; NAUSEA; NEUTROPENIA; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 34248650438     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.48.3.253     Document Type: Letter

References (47)

1. Moos DD: Sevoflurane and emergence behavioral changes in pediatrics. J Perianesth Nurs 2005; 20:13-18
2. Sikich N, Lerman J: Development and psychometric evaluation of the Pediatric Anesthesia Emergence Delirium Scale. Anesthesiology 2004; 100:1138-1145
3. Przybylo HJ, Martini DR, Mazurek AJ, et al: Assessing behaviour in children emerging from anaesthesia: can we apply psychiatric diagnostic techniques? Paediatr Anaesth 2003; 13:609-616
4. Veyckemans F: Excitation and delirium during sevoflurane anesthesia in pediatric patients. Minerva Anestesiol 2002; 68:402-405
5. Wells LT, Rasch DK: Emergence "delirium" after sevoflurane anesthesia: a paranoid delusion? Anesth Analg 1999; 88:1308-1310
6. Valley RD, Ramza JT, Calhoun P, et al: Tracheal extubation of deeply anesthetized pediatric patients: a comparison of isoflurane and sevoflurane. Anesth Analg 1999; 88:742-745
7. Meyer-Pahoulis E, Williams SL, Davidson SI, et al: The pediatric patient in the post-anesthesia care unit. Nurs Clin North Am 1993; 28:519-530
8. Ratcliff SL, Meyer WJ 3rd, Cuervo LJ, et al: The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient. J Burn Care Rehabil 2004; 25:472-478
9. Brown RL, Henke A, Greenhalgh DG, et al: The use of haloperidol in the agitated, critically ill pediatric patient with burns. J Burn Care Rehabil 1996; 17:34-38
10. Schieveld JN, Leentjens AF: Delirium in severely ill young children in the pediatric intensive care unit (PICU). J Am Acad Child Adolesc Psychiatry 2005; 44:392-395
11. Hughes J: Hallucinations following cardiac surgery in a paediatric intensive care unit. Intens Crit Care Nurs 1994; 10:209-211
12. Jones SM, Fiser DH, Livingston RL: Behavioral changes in pediatric intensive care units. Am J Dis Child 1992; 146:375-379
13. Turkel SB, Tavare CJ: Delirium in children and adolescents. J Neuropsychiatry Clin Neurosci 2003; 15:431-435
14. Cole MG, Primeau FJ: Prognosis of delirium in elderly hospital patients. CMAJ 1993; 149:41-46
15. Ely EW, Shintani A, Truman B, et al: Delirium as a predictor of mortality in mechanically-ventilated patients in the intensive care unit. JAMA 2004; 291:1753-1762
16. Martini DR: Commentary: the diagnosis of delirium in pediatric patients. J Am Acad Child Adolesc Psychiatry 2005; 44:395-398
17. Beliles KE: Alternative routes of administration of psychotropic medications, in Psychiatric Care of the Medical Patient. Edited by Stoudemire A, Fogel BS, Greenberg DB. New York, Oxford University Press, 2000, pp 395-405
18. Menza MA, Murray GB, Holmes VF, et al: Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry 1987; 48:278-280
19. Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45:297-301
20. Sipahimalani A, Masand PS: Use of risperidone in delirium: case reports. Ann Clin Psychiatry 1997; 9:105-107
21. Sipahimalani A, Masand PS: Olanzapine in the treatment of delirium. Psychosomatics 1998; 39:422-430
22. Zimnitzky BM, DeMaso DR, Steingard RJ: Use of risperidone in psychotic disorder following ischemic brain damage. J Child Adolesc Psychopharmacol 1996; 6:75-78
23. Scharko AM, Baker EH, Kothari P, et al: Case study: delirium in an adolescent girl with human immunodeficiency virus-associated dementia. J Am Acad Child Adolesc Psychiatry 2006; 45:104-108
24. de Rooij SE, Schuurmans MJ, van der Mast RC, et al: Clinical subtypes of delirium and their relevance for daily clinical practice: a systematic review. Int J Geriatr Psychiatry 2005; 20:609-615
25. Balan S, Leibovitz A, Zila SO, et al: The relationship between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci 2003; 15:363-366
26. Camus V, Gonthier R, Dubos G, et al: Etiologic and outcome profiles in hypoactive and hyperactive subtypes of delirium. J Geriatr Psychiatry Neurol 2000; 13:38-42
27. Camus V, Burtin B, Simeone I, et al: Factor analysis supports the evidence of existing hyperactive and hypoactive subtypes of delirium. Int J Geriatr Psychiatry 2000; 15:313-316
28. Turkel SB, Braslow K, Tavare CJ, et al: The Delirium Rating Scale in children and adolescents. Psychosomatics 2003; 44:126-129
29. Findling RL, Steiner H, Weller EB: Use of antipsychotics in children and adolescents. J Clin Psychiatry 2005; 66(suppl 7):29-40
30. Bourgeois JA, Hilty DM: Prolonged delirium managed with risperidone. Psychosomatics 2005; 46:90-91
31. Gupta N, Sharma P, Mattoo SK: Effectiveness of risperidone in delirium. Can J Psychiatry 2005; 50:75
32. Liu CY, Juang YY, Liang HY, et al: Efficacy of risperidone in treating the hyperactive symptoms of delirium. Int Clin Psychopharmacol 2004; 19:165-168
33. Parellada E, Baeza I, de Pablo I, et al: Risperidone in the treatment of patients with delirium. J Clin Psychiatry 2004; 65:348-353
34. Schwartz TL, Masand PS: The role of atypical antipsychotics in the treatment of delirium. Psychosomatics 2002; 43:171-174
35. Tune L: The role of antipsychotics in treating delirium. Curr Psychiatry Rep 2002; 4:209-212
36. Mittal D, Jimerson NA, Neely EP, et al: Risperidone in the treatment of delirium: results from a prospective, open-label trial. J Clin Psychiatry 2004; 65:662-667
37. Horikawa N, Yamazaki T, Miyamoto K, et al: Treatment for delirium with risperidone: results of a prospective, open trial with 10 patients. Gen Hosp Psychiatry 2003; 25:289-292
38. Trzepacz PT: Is there a final common neural pathway in delirium? focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000; 5:132-148
39. Kim JY, Jung IK, Han C, et al: Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 2005; 59:183-188
40. Wilkaitis J, Mulvihill T, Nasrallah HA: Classic antipsychotic medications, in Textbook of Psychopharmacology. Edited by Schatzberg AF, Nemeroff CB. Arlington, VA, American Psychiatric Publishing, Inc., 2004, pp 425-442
41. Goff DC: Risperidone, in Textbook of Psychopharmacology. Edited by Schatzberg AF, Nemeroff CB. Arlington, VA, American Psychiatric Publishing, Inc., 2004, pp 495-506
42. Gardner DM, Baldessarini RJ, Waraich P: Modern antipsychotic drugs: a critical overview. CMAJ 2005; 172:1703-1711
43. 2 receptor explain the action of atypical antipsychotics?: a new hypothesis. Am J Psychiatry 2001; 158:360-369
44. 1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release. J Neurochem 2001; 76:1521-1531
45. Physicians' Desk Reference (PDR): Oradell, NJ, Medical Economics Co, 2005
46. Hales RE, Yudofsky SC: The American Psychiatric Publishing Textbook of Clinical Psychiatry. Washington, DC, American Psychiatric Publishing, Inc., 2003
47. Schatzberg AF, Nemeroff CB (eds): Textbook of Psychopharmacology. Arlington, VA, American Psychiatric Publishing, 2004